Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study
Martin Magner, Kateřina Thorová, Veronika Župová, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 718-718
Open Access | Times Cited: 18

Showing 18 citing articles:

Exploring the anti‐inflammatory activity of sulforaphane
Katie Treasure, James Harris, Gary Williamson
Immunology and Cell Biology (2023) Vol. 101, Iss. 9, pp. 805-828
Open Access | Times Cited: 23
Bioactive sulforaphane from cruciferous vegetables: advances in biosynthesis, metabolism, bioavailability, delivery, health benefits, and applications
Yanli Zhang, Wenyuan Zhang, Yaqi Zhao, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-21
Closed Access | Times Cited: 9
Therapeutic diets and supplementation: exploring their impact on autism spectrum disorders in childhood – A narrative review of recent clinical trials
Rouzha Pancheva, Rositsa Chamova, Dimitar Marinov, et al.
Research in autism spectrum disorders (2024) Vol. 112, pp. 102352-102352
Open Access | Times Cited: 6
The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and update
Monica Ramakrishnan, Jed W. Fahey, Andrew W. Zimmerman, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 5
Therapeutic efficacy of sulforaphane in autism spectrum disorders and its association with gut microbiota: animal model and human longitudinal studies
Jiexian Yang, Li He, Si Dai, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 4
Effects of sulforaphane on ABC and SRS scales in patients with autism spectrum disorder: a meta-analysis
Jialing Guo, Yichao Wang, Weijun He, et al.
Brain and Development (2025) Vol. 47, Iss. 2, pp. 104321-104321
Open Access
Prescribing in Children and Adolescents

(2025), pp. 561-626
Closed Access
Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders
Jed W. Fahey, Hua Liu, Holly Batt, et al.
Nutrients (2025) Vol. 17, Iss. 8, pp. 1353-1353
Open Access
Thioredoxin 1 and Thioredoxin Reductase 1 Redox System Is Dysregulated in Neutrophils of Subjects with Autism: In Vitro Effects of Environmental Toxicant, Methylmercury
Samiyah Alshehri, Sheikh F. Ahmad, Norah A. Albekairi, et al.
Toxics (2023) Vol. 11, Iss. 9, pp. 739-739
Open Access | Times Cited: 6
Comment on Magner et al. Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. Nutrients 2023, 15, 718
Luke Curtis
Nutrients (2024) Vol. 16, Iss. 5, pp. 673-673
Open Access | Times Cited: 1
Sulforaphane protects against LPS-induced liver injury in mice by antagonizing oxidative stress and apoptosis through AMPK activation.
Rasha A. Mansouri, Huda F. Alshaibi, May Alqurashi, et al.
PubMed (2024) Vol. 18, Iss. 3, pp. 39-47
Closed Access | Times Cited: 1
Estratégias Terapêuticas para o Transtorno do Espectro Autista: Abordagens para o Desenvolvimento Infantil
Ellen Vitória Rodrigues de Lima Freire, Jaine Amorim Araujo, Renan Barros Braga, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 8, pp. 1269-1283
Open Access
A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants
Glen Clack, Christopher M. Moore, Linette Ruston, et al.
Advances in Therapy (2024)
Open Access
Sulforaphane suppresses Aβ accumulation and tau hyperphosphorylation in vascular cognitive impairment(VCI)
Cong Li, Lei Zhang, Xin Li, et al.
The Journal of Nutritional Biochemistry (2024), pp. 109803-109803
Closed Access
Reply to Curtis, L. Comment on “Magner et al. Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. Nutrients 2023, 15, 718”
Martin Magner, Ivana Švandová, Milan Houška
Nutrients (2024) Vol. 16, Iss. 5, pp. 674-674
Open Access
Anti-Inflammatory Interventions for Autism Spectrum Disorder
Haily Holston, Avani Karvat, Simran Lallian, et al.
Berkeley Pharma Tech Journal of Medicine (2024) Vol. 4, Iss. 1, pp. 59-82
Open Access
Complementary and Alternative Medicine for Autism – A Systematic Review
Monica Doherty, Kitty‐Rose Foley, Janet Schloss
Journal of Autism and Developmental Disorders (2024)
Open Access
Repairing muscle with broccoli-derived sulforaphane: A preclinical evaluation for the treatment of mitochondrial myopathies
Thomas M. Lilley, Donny M. Camera, Faith Kwa
Drug Discovery Today (2024), pp. 104283-104283
Open Access
Current evidences of therapeutic effects of sulforaphane on oral and intestinal microbiota in Autism Spectrum Disorder – ASD
Melissa Bomfim Damasceno, Luciane Fernanda Rodrigues Martinho Fernandes, Letícia Silva, et al.
Concilium (2023) Vol. 23, Iss. 19, pp. 203-217
Open Access
Page 1

Scroll to top